Table 5 Genotype distribution of the PROCR polymorphisms in CAD patients according to the outcome during follow-up
No cardiovascular event N = 805 | Cardiovascular events N = 77 | |
|---|---|---|
rs6088738 | ||
GG | 469 (59%) | 46 (60%) |
GA | 291 (36%) | 28 (36%) |
AA | 40 (5%) | 3 (4%) |
MAF(1) | 0.232 | 0.221 |
P(2) | p = 0.752 | |
rs6088747 | ||
TT | 280 (35%) | 18 (24%) |
TG | 380 (47%) | 43 (56%) |
GG | 145 (18%) | 16 (20% |
MAF | 0.416 | 0.487 |
P | p = 0.092 | |
rs867186 | ||
AA | 639 (79%) | 62 (80%) |
AG | 157 (20%) | 13 (17%) |
GG | 9 (1%) | 2 (3%) |
MAF | 0.109 | 0.110 |
P | p = 0.948 | |